Triclofos

This classification denotes a sedative and hypnotic with the molecular formula C2H4Cl3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J712EO9048, chemically known as 2,2,2-trichloroethyl phosphate but generally known as triclofos, which bears US NIH Compound Identifier 5563. European Medicines Agency schedules Triclofos in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11274MIG. The term TRICLOFOS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules triclofos in its Anatomical Therapeutic Chemical (ATC) Classification. TRICLOFOS is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule triclofos under HS 29199090 and SITC 51631. As of Q4 2014, TRICLOFOS remains the US FDA Preferred Term for this commodity. Triclofos bears US NLM identifiers UMLS ID C0077073 and NCI Concept Code C87206. SMILES: CLC(CL)(CL)COP(=O)(O)O.